151 related articles for article (PubMed ID: 35608483)
1. Bullous pemphigoid after inactivated COVID-19 vaccination: Case report.
Zhang Y; Lang X; Guo S; He H; Cui H
Dermatol Ther; 2022 Aug; 35(8):e15595. PubMed ID: 35608483
[No Abstract] [Full Text] [Related]
2. Can Covid-19 vaccines cause or exacerbate bullous pemphigoid? A report of seven cases from one center.
Afacan E; Edek YC; İlter N; Gülekon A
Int J Dermatol; 2022 May; 61(5):626-627. PubMed ID: 35080255
[No Abstract] [Full Text] [Related]
3. Reply to: 'Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab' by Baffa et al.
Sun L; Brazão C; Mancha D; Soares-de-Almeida L; Filipe P
J Eur Acad Dermatol Venereol; 2023 May; 37(5):e578-e580. PubMed ID: 36681888
[No Abstract] [Full Text] [Related]
4. Oral mucous membrane pemphigoid after SARS-CoV-2 vaccination.
Calabria E; Antonelli A; Lavecchia A; Giudice A
Oral Dis; 2024 Mar; 30(2):782-783. PubMed ID: 36516333
[No Abstract] [Full Text] [Related]
5. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination.
Tomayko MM; Damsky W; Fathy R; McMahon DE; Turner N; Valentin MN; Rallis T; Aivaz O; Fox LP; Freeman EE
J Allergy Clin Immunol; 2021 Sep; 148(3):750-751. PubMed ID: 34275656
[No Abstract] [Full Text] [Related]
6. Reply to "New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin".
Maronese CA; Di Zenzo G; Genovese G; Barei F; Monestier A; Pira A; Moltrasio C; Marzano AV
Dermatol Ther; 2022 Jun; 35(6):e15496. PubMed ID: 35388592
[No Abstract] [Full Text] [Related]
7. Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to 'Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review' by Pauluzzi et al.
Martora F; Ruggiero A; Battista T; Fabbrocini G; Megna M
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e35-e36. PubMed ID: 35974447
[No Abstract] [Full Text] [Related]
8. A case of anti-p200 pemphigoid after COVID-19 vaccination.
Shimamoto K; Someda Y; Ushimura A; Tateishi C; Hayashi D; Tsuruta D; Hashimoto T; Goto H
Eur J Dermatol; 2024 Apr; 34(2):220-221. PubMed ID: 38907563
[No Abstract] [Full Text] [Related]
9. A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination.
Daines B; Madigan LM; Vitale PA; Khalighi M; Innes M
Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259862
[TBL] [Abstract][Full Text] [Related]
10. New-onset bullous pemphigoid and flare of pre-existing bullous pemphigoid after the third dose of the COVID-19 vaccine.
Bardazzi F; Carpanese MA; Abbenante D; Filippi F; Sacchelli L; Loi C
Dermatol Ther; 2022 Jul; 35(7):e15555. PubMed ID: 35510556
[No Abstract] [Full Text] [Related]
11. Reply to 'The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al.
Avallone G; Giordano S; Astrua C; Merli M; Senetta R; Conforti C; Ribero S; Marzano AV; Quaglino P
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e433-e435. PubMed ID: 35067994
[No Abstract] [Full Text] [Related]
12. Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination.
Hung WK; Chi CC
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e407-e409. PubMed ID: 35073431
[No Abstract] [Full Text] [Related]
13. New-Onset Pemphigoid Gestationis Following COVID-19 Vaccination.
Mustin DE; Huffaker TB; Feldman RJ
Cutis; 2023 May; 111(5):E2-E4. PubMed ID: 37406312
[No Abstract] [Full Text] [Related]
14. New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin.
Bostan E; Yel B; Akdogan N; Gokoz O
Dermatol Ther; 2022 Feb; 35(2):e15241. PubMed ID: 34854184
[No Abstract] [Full Text] [Related]
15. Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.
Birabaharan M; Kaelber DC; Orme CM; Paravar T; Karris MY
Br J Dermatol; 2022 Aug; 187(2):271-273. PubMed ID: 35279833
[No Abstract] [Full Text] [Related]
16. Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.
Dell'Antonia M; Anedda S; Usai F; Atzori L; Ferreli C
Dermatol Ther; 2022 Jan; 35(1):e15208. PubMed ID: 34786801
[No Abstract] [Full Text] [Related]
17. Case of bullous pemphigoid following coronavirus disease 2019 vaccination.
Nakamura K; Kosano M; Sakai Y; Saito N; Takazawa Y; Omodaka T; Kiniwa Y; Okuyama R
J Dermatol; 2021 Dec; 48(12):e606-e607. PubMed ID: 34545973
[No Abstract] [Full Text] [Related]
18. Infantile bullous pemphigoid following vaccination.
Guerra L; Pedicelli C; Fania L; De Luca N; Condorelli AG; Mazzanti C; Di Zenzo G
Eur J Dermatol; 2018 Oct; 28(5):708-710. PubMed ID: 30325317
[No Abstract] [Full Text] [Related]
19. Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab.
Baffa ME; Maglie R; Montefusco F; Pipitò C; Senatore S; Antiga E
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e135-e137. PubMed ID: 36268775
[No Abstract] [Full Text] [Related]
20. Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies.
Gambichler T; Hamdani N; Budde H; Sieme M; Skrygan M; Scholl L; Dickel H; Behle B; Ganjuur N; Scheel C; Abu Rached N; Ocker L; Stranzenbach R; Doerler M; Pfeiffer L; Becker JC
Br J Dermatol; 2022 Apr; 186(4):728-731. PubMed ID: 34773638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
